BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35588691)

  • 1. Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants.
    Lee A; Wimmers F; Pulendran B
    Curr Opin Immunol; 2022 Aug; 77():102189. PubMed ID: 35588691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
    Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
    Front Immunol; 2018; 9():2936. PubMed ID: 30619296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine adjuvants: putting innate immunity to work.
    Coffman RL; Sher A; Seder RA
    Immunity; 2010 Oct; 33(4):492-503. PubMed ID: 21029960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging concepts in the science of vaccine adjuvants.
    Pulendran B; S Arunachalam P; O'Hagan DT
    Nat Rev Drug Discov; 2021 Jun; 20(6):454-475. PubMed ID: 33824489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of adjuvants for vaccines targeting specific pathogens.
    Sarkar I; Garg R; van Drunen Littel-van den Hurk S
    Expert Rev Vaccines; 2019 May; 18(5):505-521. PubMed ID: 31009255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic vaccines: the role of adjuvants in immune targeting.
    Jiang ZH; Koganty RR
    Curr Med Chem; 2003 Aug; 10(15):1423-39. PubMed ID: 12871139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
    Marciani DJ
    Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The science of adjuvants.
    Kwissa M; Kasturi SP; Pulendran B
    Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Phenolics and Lectins as Vaccine Adjuvants.
    Reyna-Margarita HR; Irais CM; Mario-Alberto RG; Agustina RM; Luis-Benjamín SG; David PE
    Curr Pharm Biotechnol; 2019; 20(15):1236-1243. PubMed ID: 31333121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.
    Akache B; Stark FC; Agbayani G; Renner TM; McCluskie MJ
    Methods Mol Biol; 2022; 2412():179-231. PubMed ID: 34918246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adjuvants in modeling the immune response.
    Carter D; Reed SG
    Curr Opin HIV AIDS; 2010 Sep; 5(5):409-13. PubMed ID: 20978382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine adjuvants: Tailoring innate recognition to send the right message.
    Lavelle EC; McEntee CP
    Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate sensors that regulate vaccine responses.
    Georg P; Sander LE
    Curr Opin Immunol; 2019 Aug; 59():31-41. PubMed ID: 30978666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in vaccine adjuvants.
    Schijns VE; Lavelle EC
    Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.
    Del Giudice G; Rappuoli R; Didierlaurent AM
    Semin Immunol; 2018 Oct; 39():14-21. PubMed ID: 29801750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of polymer-based particulate vaccine adjuvants.
    Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
    Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvants.
    Carter D; Duthie MS; Reed SG
    Curr Top Microbiol Immunol; 2020; 428():103-127. PubMed ID: 30043342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.